Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/20/18 | SC TO-I/A | Issuer tender offer statement |
|
4 | |
| 03/20/18 | 8-K | Current report filing |
|
5 | |
| 03/20/18 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/20/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 03/19/18 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/14/18 | SC TO-I/A | Issuer tender offer statement |
|
4 | |
| 03/14/18 | 8-K | Current report filing |
|
5 | |
| 03/09/18 | S-3 | Registration statement for specified transactions by certain issuers |
|
39 | |
| 03/09/18 | 424B2 | Prospectus filed pursuant to Rule 424(b)(2) |
|
55 | |
| 03/09/18 | 424B2 | Prospectus filed pursuant to Rule 424(b)(2) |
|
36 |
